Search

Vy Q. Bui

Examiner (ID: 7508)

Most Active Art Unit
3773
Art Unit(s)
3731, 3733, 3734, 3773, 3771
Total Applications
1467
Issued Applications
994
Pending Applications
193
Abandoned Applications
280

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18192562 [patent_doc_number] => 20230046081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => SYNERGISTIC ACTIVITY OF NOVEL COMPOUNDS AGAINST PLANKTONIC AND BIOFILM CELLS OF CLINICALLY RELEVANT PATHOGENS [patent_app_type] => utility [patent_app_number] => 17/874526 [patent_app_country] => US [patent_app_date] => 2022-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874526 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/874526
SYNERGISTIC ACTIVITY OF NOVEL COMPOUNDS AGAINST PLANKTONIC AND BIOFILM CELLS OF CLINICALLY RELEVANT PATHOGENS Jul 26, 2022 Pending
Array ( [id] => 18240428 [patent_doc_number] => 20230072739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => COMBINATION THERAPY TREATMENT USING TRANSDERMAL DELIVERY SYSTEM [patent_app_type] => utility [patent_app_number] => 17/809191 [patent_app_country] => US [patent_app_date] => 2022-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34268 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17809191 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/809191
COMBINATION THERAPY TREATMENT USING TRANSDERMAL DELIVERY SYSTEM Jun 26, 2022 Abandoned
Array ( [id] => 17911247 [patent_doc_number] => 20220313642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => TYROSINE DERIVATIVES AND COMPOSITIONS COMPRISING THEM [patent_app_type] => utility [patent_app_number] => 17/847951 [patent_app_country] => US [patent_app_date] => 2022-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7246 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17847951 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/847951
TYROSINE DERIVATIVES AND COMPOSITIONS COMPRISING THEM Jun 22, 2022 Abandoned
Array ( [id] => 17881161 [patent_doc_number] => 20220296638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => METHOD OF TREATING MIGRAINES AND HEADACHES [patent_app_type] => utility [patent_app_number] => 17/835805 [patent_app_country] => US [patent_app_date] => 2022-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5274 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835805 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/835805
Method of treating migraines and headaches Jun 7, 2022 Issued
Array ( [id] => 18034512 [patent_doc_number] => 20220378727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => DRY POWDER FORMULATIONS OF TAMIBAROTENE FOR PULMONARY AND INTRANASAL DELIVERY [patent_app_type] => utility [patent_app_number] => 17/743271 [patent_app_country] => US [patent_app_date] => 2022-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27211 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743271 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/743271
DRY POWDER FORMULATIONS OF TAMIBAROTENE FOR PULMONARY AND INTRANASAL DELIVERY May 11, 2022 Abandoned
Array ( [id] => 19242028 [patent_doc_number] => 12012447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-18 [patent_title] => Compositions and methods for reducing at least one symptom of human allergy to cats [patent_app_type] => utility [patent_app_number] => 17/731403 [patent_app_country] => US [patent_app_date] => 2022-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4383 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/731403
Compositions and methods for reducing at least one symptom of human allergy to cats Apr 27, 2022 Issued
Array ( [id] => 20200344 [patent_doc_number] => 12403109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-02 [patent_title] => Sotalol hydrochloride dosing [patent_app_type] => utility [patent_app_number] => 17/725189 [patent_app_country] => US [patent_app_date] => 2022-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1709 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725189 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/725189
Sotalol hydrochloride dosing Apr 19, 2022 Issued
Array ( [id] => 17641770 [patent_doc_number] => 20220169508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/671540 [patent_app_country] => US [patent_app_date] => 2022-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17671540 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/671540
PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF Feb 13, 2022 Abandoned
Array ( [id] => 18747138 [patent_doc_number] => 11806429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-07 [patent_title] => Film formulations containing dexmedetomidine and methods of producing them [patent_app_type] => utility [patent_app_number] => 17/579914 [patent_app_country] => US [patent_app_date] => 2022-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 32115 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579914 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/579914
Film formulations containing dexmedetomidine and methods of producing them Jan 19, 2022 Issued
Array ( [id] => 18970373 [patent_doc_number] => 20240050465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => HYDROGEN WATER FOR PREVENTION OF ALCOHOLIC HEPATOPATHY [patent_app_type] => utility [patent_app_number] => 18/264815 [patent_app_country] => US [patent_app_date] => 2022-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5774 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264815 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/264815
HYDROGEN WATER FOR PREVENTION OF ALCOHOLIC HEPATOPATHY Jan 10, 2022 Pending
Array ( [id] => 18994660 [patent_doc_number] => 11911477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Use of fructose in preparing drug for treating ischemic injury [patent_app_type] => utility [patent_app_number] => 17/646935 [patent_app_country] => US [patent_app_date] => 2022-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 29 [patent_no_of_words] => 4480 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17646935 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/646935
Use of fructose in preparing drug for treating ischemic injury Jan 3, 2022 Issued
Array ( [id] => 20293828 [patent_doc_number] => 20250319071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-16 [patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING TEGOPRAZAN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [patent_app_type] => utility [patent_app_number] => 18/269421 [patent_app_country] => US [patent_app_date] => 2021-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269421 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/269421
PHARMACEUTICAL COMPOSITION COMPRISING TEGOPRAZAN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS Dec 28, 2021 Pending
Array ( [id] => 17625614 [patent_doc_number] => 20220160629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM [patent_app_type] => utility [patent_app_number] => 17/560423 [patent_app_country] => US [patent_app_date] => 2021-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32161 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560423 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/560423
Film formulations containing dexmedetomidine and methods of producing them Dec 22, 2021 Issued
Array ( [id] => 17996625 [patent_doc_number] => 11497711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-15 [patent_title] => Film formulations containing dexmedetomidine and methods of producing them [patent_app_type] => utility [patent_app_number] => 17/560392 [patent_app_country] => US [patent_app_date] => 2021-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 32144 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560392 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/560392
Film formulations containing dexmedetomidine and methods of producing them Dec 22, 2021 Issued
Array ( [id] => 17685828 [patent_doc_number] => 20220193120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR MAINTAINING LUNG FUNCTION IN HUMAN LUNG CANCER AND/OR IMPROVING REDUCTION IN LUNG FUNCTION ATTRIBUTED TO HUMAN LUNG CANCER [patent_app_type] => utility [patent_app_number] => 17/552193 [patent_app_country] => US [patent_app_date] => 2021-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5107 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552193 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/552193
MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR MAINTAINING LUNG FUNCTION IN HUMAN LUNG CANCER AND/OR IMPROVING REDUCTION IN LUNG FUNCTION ATTRIBUTED TO HUMAN LUNG CANCER Dec 14, 2021 Abandoned
Array ( [id] => 19608026 [patent_doc_number] => 12156885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => Methods and compositions for treating heart conditions [patent_app_type] => utility [patent_app_number] => 17/541533 [patent_app_country] => US [patent_app_date] => 2021-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5297 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541533 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/541533
Methods and compositions for treating heart conditions Dec 2, 2021 Issued
Array ( [id] => 17640622 [patent_doc_number] => 20220168360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => COMPOSITIONS, DEVICES, AND METHODS FOR TREATING RESPIRATORY DISORDERS [patent_app_type] => utility [patent_app_number] => 17/539595 [patent_app_country] => US [patent_app_date] => 2021-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21004 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539595 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/539595
COMPOSITIONS, DEVICES, AND METHODS FOR TREATING RESPIRATORY DISORDERS Nov 30, 2021 Pending
Array ( [id] => 17640453 [patent_doc_number] => 20220168191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => PROCESS FOR THE PREPARATION OF A READY-TO-USE, COSMETIC, FLOWABLE DETERGENT [patent_app_type] => utility [patent_app_number] => 17/537635 [patent_app_country] => US [patent_app_date] => 2021-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6375 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17537635 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/537635
Process for the preparation of a ready-to-use, cosmetic, flowable detergent Nov 29, 2021 Issued
Array ( [id] => 18970420 [patent_doc_number] => 20240050512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => REDUCTION OF VIRAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/265981 [patent_app_country] => US [patent_app_date] => 2021-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265981 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/265981
REDUCTION OF VIRAL INFECTIONS Nov 24, 2021 Pending
Array ( [id] => 19608027 [patent_doc_number] => 12156886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => Methods of increasing blood oxygen saturation [patent_app_type] => utility [patent_app_number] => 17/525841 [patent_app_country] => US [patent_app_date] => 2021-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 17144 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525841 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/525841
Methods of increasing blood oxygen saturation Nov 11, 2021 Issued
Menu